(Q38033680)

27 August 2017

title

Cognitive dysfunction: an emerging concept of a new diabetic complication in the elderly (English)

1 reference

complications of diabetes mellitus

27 August 2017

main subject

cognitive dysfunction

1 reference

based on heuristic

inferred from title

1 reference

Hiroyuki Umegaki

1

1 reference

27 August 2017

Toshio Hayashi

2

1 reference

27 August 2017

Hideki Nomura

3

1 reference

27 August 2017

Madoka Yanagawa

4

1 reference

27 August 2017

Zen Nonogaki

5

1 reference

27 August 2017

Hirotaka Nakshima

6

1 reference

27 August 2017

Masafumi Kuzuya

7

1 reference

27 August 2017

publication date

6 August 2012

1 reference

Geriatrics and Gerontology International

27 August 2017

published in

1 reference

27 August 2017

volume

13

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

28-34

1 reference

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Cause-specific mortality in diabetes: recent changes in trend mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Glucose tolerance status and risk of dementia in the community: the Hisayama study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Fasting insulin and incident dementia in an elderly population of Japanese-American men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Risk of incident Alzheimer's disease in diabetic patients: a systematic review of prospective trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Risk of dementia in diabetes mellitus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Risk factors and preventive interventions for Alzheimer disease: state of the science

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

The projected effect of risk factor reduction on Alzheimer's disease prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Differential mini-mental state examination profiles of older people with diabetes mellitus with early Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Discrimination between stages of Alzheimer's disease with subsets of Mini-Mental State Examination items. An analysis of Consortium to Establish a Registry for Alzheimer's Disease data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Glucose control levels, ischaemic brain lesions, and hyperinsulinaemia were associated with cognitive dysfunction in diabetic elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Factors associated with cognitive decline in elderly diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Food-derived advanced glycation end products (AGEs): a novel therapeutic target for various disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Insulin and the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Insulin receptors are widely distributed in the central nervous system of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Insulin receptors and insulin actions in the nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Intranasal insulin improves memory in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Common pathological processes in Alzheimer disease and type 2 diabetes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Neurovascular coupling in cognitive impairment associated with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Cell-cell signaling in the neurovascular unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Treatment of vascular risk factors is associated with slower decline in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

An investigation of the population impact of variation in HbA1c levels in older people in England and Wales: from a population based multi-centre longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Diabetes as a risk factor for cognitive decline in older patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Glycated haemoglobin and cognitive decline: the Atherosclerosis Risk in Communities (ARIC) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Short-term effects of improved glycemic control on cognitive function in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Improving metabolic control leads to better working memory in adults with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Effects of improved glycaemic control maintained for 3 months on cognitive function in patients with Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Insulin resistance and postprandial hyperglycemia the bad companions in natural history of diabetes: effects on health of vascular tree

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

The impact of cognitive functioning on mortality and the development of functional disability in older adults with diabetes: the second longitudinal study on aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Late-life depression, mild cognitive impairment, and dementia: possible continuum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Cognitive and psychosocial aspects of caring for elderly patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Depression and poor glycemic control: a meta-analytic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Differential association of concurrent, baseline, and average depressive symptoms with cognitive decline in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Depressive symptoms and cognitive decline in late life: a prospective epidemiological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00922.X

10.1111/J.1447-0594.2012.00922.X

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference